It seems humanity would soon have a breath of fresh air as Sao Paulo State Governor Joao Doria on Tuesday displayed a box of the COVID-19 vaccine produced by the Chinese company Sinovac Biotech at the Hospital das Clinicas (HC) in Sao Paulo State.
The occasion was a press conference where the governor said the vaccine trial will be carried out in Brazil in partnership with the Brazilian Research Institute Butanta.
The vaccine has therefore entered the final stage of testing as volunteers received the first doses of what officials hope will be a game-changer in the global pandemic.
“We’re living in unique and historic times, and that’s why I wanted to be part of this trial,” said the 27-year-old doctor who received the first dose at the Clinical Hospital of Sao Paulo.
Around 9,000 health workers across six Brazilian states will receive the vaccine, known as CoronaVac, in two doses over the next three months under the study. Sao Paulo Governor Joao Doria said Monday initial results were expected within 90 days.
If the vaccine proves safe and effective, the institute will have the right to produce 120 million doses under the deal, according to officials.
Brazil is the second-hardest-hit country in the coronavirus pandemic, after the United States with death toll surpassing 80,000 as at Monday. It also has registered 2.1 million infections.